A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis

Clinical trial NCT07558668 · RECRUITING

Trial details

NCT number: NCT07558668
Sponsor: Sitryx Therapeutics Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate to Severe Atopic Dermatitis

Start date: 2025-02-26
Primary completion: 2026-08-30
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.